Stock Analysts' Upgrades for June 1st (APLT, ARHS, ASTS, ATHX, ATNM, ATTO, AURA, AVDX, BAK, BBLN)
Stock Analysts’ upgrades for Wednesday, June 1st: Applied Therapeutics (NASDAQ:APLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.50 target price on the stock. According to Zacks, “Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet […]